In a long‑term care patient with a critical serum potassium of 7.4 mmol/L (previously 4.0 mmol/L, prior critical 6.0 mmol/L rechecked at 4.4 mmol/L), what immediate management steps should be taken and what causes should be assessed for?

Immediate Management of Critical Potassium 7.4 in Long-Term Care

This is almost certainly pseudohyperkalemia from hemolysis or improper specimen handling, given the midnight draw, 3-state shipping delay, and history of a prior "critical" 6.0 that rechecked at 4.4—do NOT treat emergently until you immediately recheck with a proper stat sample and obtain an ECG.

First Priority: Verify This is Real

The clinical scenario screams pseudohyperkalemia 1:

• Midnight blood draw shipped across 3 states = prolonged transport time allowing cellular breakdown
• Prior identical pattern: K 6.0 → recheck 4.4
• Recent normal K of 4.0
• Patient in long-term care (likely stable, not acutely ill)

Immediate actions:

1. Obtain ECG immediately - If truly 7.4, you would expect peaked T waves, widened QRS, or worse. Normal ECG strongly suggests pseudohyperkalemia 1, 2
2. Recheck potassium STAT with proper technique:
   • No fist clenching during draw
   • Large bore needle to prevent hemolysis
   • Process sample immediately at local facility
   • Consider arterial sample if venous repeatedly elevated 1
3. Assess patient clinically - Are they symptomatic? Weakness? Palpitations? (Likely asymptomatic if pseudohyperkalemia)

If ECG Shows Hyperkalemic Changes OR Patient Symptomatic

Only then proceed with emergency treatment 1, 3:

Step 1: Cardiac Membrane Stabilization (within minutes)

• IV calcium gluconate or calcium chloride - Does not lower K but prevents arrhythmias
• Consider hypertonic saline if hyponatremic

Step 2: Shift Potassium Intracellularly (onset 15-30 min, lasts 2-4 hours)

• IV insulin (10 units) with glucose (unless hyperglycemic)
• Nebulized albuterol (10-20 mg) or IV beta-agonist
• Sodium bicarbonate if metabolic acidosis present

Step 3: Remove Potassium from Body (definitive treatment)

• Loop diuretics IV if not volume depleted
• Potassium binders: Newer agents (sodium zirconium cyclosilicate or patiromer) preferred over sodium polystyrene sulfonate due to better safety profile 1, 4, 5
• Hemodialysis if severe renal failure or refractory hyperkalemia

What to Assess For (If Truly Hyperkalemic)

Medication review - Most common culprit 1:

• RAASi (ACE inhibitors, ARBs, MRAs, sacubitril/valsartan)
• NSAIDs
• Potassium-sparing diuretics
• Trimethoprim, heparin
• Potassium supplements or salt substitutes

Clinical conditions increasing risk 6, 1:

• Acute kidney injury or worsening CKD
• Volume depletion/dehydration
• Metabolic acidosis
• Tissue breakdown (infection, fever, trauma)
• Diabetes with hyporeninemic hypoaldosteronism
• Heart failure exacerbation

Dietary/supplement intake:

• High potassium foods (though dietary restriction alone rarely causes severe hyperkalemia 4)
• Herbal supplements (noni juice, nettle, others) 1
• Stored blood products if recent transfusion

Critical Pitfall to Avoid

Do not discontinue RAASi therapy reflexively 6, 1. RAASi down-titration/discontinuation is associated with increased mortality, HF hospitalizations, and progression to ESKD. Instead, manage hyperkalemia with other measures (diuretics, potassium binders, dietary counseling) to allow continuation of life-saving RAASi therapy at optimal doses 6, 1.

Most Likely Scenario

Given this patient's pattern, you will find:

• Normal or near-normal ECG
• Recheck potassium 4.0-5.0 range
• Hemolyzed specimen on original sample
• No acute intervention needed beyond addressing specimen collection/handling protocols at the facility

The history of K 6.0→4.4 on recheck is pathognomonic for recurrent pseudohyperkalemia from specimen handling issues in this long-term care setting with remote laboratory processing 1.